Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.54B |
| 2 |
ExxonMobil
XOM
|
+$905M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$791M |
| 4 |
Uber
UBER
|
+$725M |
| 5 |
Micron Technology
MU
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$735M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$718M |
| 4 |
Colgate-Palmolive
CL
|
+$406M |
| 5 |
Progressive
PGR
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.06% |
| 2 | Healthcare | 12.15% |
| 3 | Consumer Discretionary | 11.55% |
| 4 | Financials | 11.3% |
| 5 | Communication Services | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Kontoor Brands
KTB
$4.62B
| $161K | ﹤0.01% |
2,477
-104,190
| -98% | -$6.81M |
|
1527
Trupanion
TRUP
$1.05B
| $160K | ﹤0.01% |
5,563
-778
| -12% | -$20.6K |
|
1528
Safety Insurance
SAFT
$1.52B
| $159K | ﹤0.01% |
2,130
-495
| -19% | -$38.9K |
|
1529
Collegium Pharmaceutical
COLL
$1.14B
| $158K | ﹤0.01% |
+4,896
| New | +$170K |
|
1530
Ultragenyx Pharmaceutical
RARE
$2.65B
| $158K | ﹤0.01% |
3,938
-15,712
| -80% | -$671K |
|
1531
Bristow Group
VTOL
$1.35B
| $157K | ﹤0.01% |
4,698
+437
| +10% | +$13.5K |
|
1532
Columbus McKinnon
CMCO
$465M
| $156K | ﹤0.01% |
+4,636
| New | +$188K |
|
|
CWAN
1533
DELISTED
Clearwater Analytics
CWAN
| $155K | ﹤0.01% |
+8,351
| New | +$151K |
|
1534
Oportun Financial
OPRT
$257M
| $155K | ﹤0.01% |
+60,172
| New | +$182K |
|
1535
Ubiquiti
UI
$31.8B
| $155K | ﹤0.01% |
1,045
+272
| +35% | +$34.9K |
|
1536
Kinetik
KNTK
$3.71B
| $154K | ﹤0.01% |
3,600
| – | – |
|
|
ACH
1537
Accendra Health
ACH
$240M
| $154K | ﹤0.01% |
11,724
-1,689
| -13% | -$34.6K |
|
1538
Harmony Biosciences
HRMY
$2.04B
| $152K | ﹤0.01% |
+4,924
| New | +$148K |
|
1539
United Natural Foods
UNFI
$3.01B
| $152K | ﹤0.01% |
12,377
-903
| -7% | -$10.1K |
|
1540
Pacira BioSciences
PCRX
$1.02B
| $151K | ﹤0.01% |
+6,972
| New | +$198K |
|
1541
Artivion
AORT
$1.23B
| $151K | ﹤0.01% |
5,828
-1,093
| -16% | -$24.5K |
|
1542
Arcus Biosciences
RCUS
$3.57B
| $149K | ﹤0.01% |
10,392
+826
| +9% | +$13.3K |
|
1543
Embecta
EMBC
$195M
| $148K | ﹤0.01% |
12,204
-578
| -5% | -$7.02K |
|
1544
iShares MSCI Hong Kong ETF
EWH
$1.22B
| $148K | ﹤0.01% |
9,500
-74,000
| -89% | -$1.2M |
|
|
FBRT
1545
Franklin BSP Realty Trust
FBRT
$601M
| $147K | ﹤0.01% |
11,758
-2,809
| -19% | -$35.8K |
|
1546
Criteo
CRTO
$1.03B
| $147K | ﹤0.01% |
3,768
| – | – |
|
1547
Hims & Hers Health
HIMS
$6.5B
| $146K | ﹤0.01% |
7,112
+167
| +2% | +$2.78K |
|
1548
Interface
TILE
$1.91B
| $146K | ﹤0.01% |
9,798
-1,574
| -14% | -$24.5K |
|
1549
Quanex
NX
$854M
| $146K | ﹤0.01% |
5,411
-443
| -8% | -$14.7K |
|
1550
National Vision
EYE
$1.6B
| $145K | ﹤0.01% |
11,694
-2,529
| -18% | -$41.4K |
|
Similar funds
Amundi's Q2 2024 Portfolio in Review
As of Q2 2024, Amundi held 2,114 positions worth $261B, up 12% from $233B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Amundi's Q2 2024 filing shows 127 new, 621 increased, 973 reduced and 191 closed positions. Its largest new stake was GE Vernova: 1,692,458 shares worth $292M. The largest sale was Meta Platforms (Facebook), an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q2 2024 buy was GE Vernova: 1,692,458 shares worth $292M.
- Amundi added most to Apple in Q2 2024, an estimated $1.54B increase.
- Amundi's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $1.51B.
- Amundi fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $207M.
- Amundi's ten largest holdings make up 27% of its $261B portfolio in Q2 2024.
- Amundi opened 127 new positions and closed 191 in Q2 2024.
- Amundi's portfolio value rose 12% quarter-over-quarter to $261B.
Based on Amundi's 13F filing for Q2 2024, filed 14 Aug 2024.